Cargando…
Endocarditis following ocrelizumab in relapsing-remitting MS
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051193/ https://www.ncbi.nlm.nih.gov/pubmed/32014890 http://dx.doi.org/10.1212/NXI.0000000000000680 |
| _version_ | 1783502727392788480 |
|---|---|
| author | Faissner, Simon Schwake, Carolin Gotzmann, Michael Mügge, Andreas Schmidt, Stephan Gold, Ralf |
| author_facet | Faissner, Simon Schwake, Carolin Gotzmann, Michael Mügge, Andreas Schmidt, Stephan Gold, Ralf |
| author_sort | Faissner, Simon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7051193 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70511932020-03-13 Endocarditis following ocrelizumab in relapsing-remitting MS Faissner, Simon Schwake, Carolin Gotzmann, Michael Mügge, Andreas Schmidt, Stephan Gold, Ralf Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2020-02-03 /pmc/articles/PMC7051193/ /pubmed/32014890 http://dx.doi.org/10.1212/NXI.0000000000000680 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Clinical/Scientific Notes Faissner, Simon Schwake, Carolin Gotzmann, Michael Mügge, Andreas Schmidt, Stephan Gold, Ralf Endocarditis following ocrelizumab in relapsing-remitting MS |
| title | Endocarditis following ocrelizumab in relapsing-remitting MS |
| title_full | Endocarditis following ocrelizumab in relapsing-remitting MS |
| title_fullStr | Endocarditis following ocrelizumab in relapsing-remitting MS |
| title_full_unstemmed | Endocarditis following ocrelizumab in relapsing-remitting MS |
| title_short | Endocarditis following ocrelizumab in relapsing-remitting MS |
| title_sort | endocarditis following ocrelizumab in relapsing-remitting ms |
| topic | Clinical/Scientific Notes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051193/ https://www.ncbi.nlm.nih.gov/pubmed/32014890 http://dx.doi.org/10.1212/NXI.0000000000000680 |
| work_keys_str_mv | AT faissnersimon endocarditisfollowingocrelizumabinrelapsingremittingms AT schwakecarolin endocarditisfollowingocrelizumabinrelapsingremittingms AT gotzmannmichael endocarditisfollowingocrelizumabinrelapsingremittingms AT muggeandreas endocarditisfollowingocrelizumabinrelapsingremittingms AT schmidtstephan endocarditisfollowingocrelizumabinrelapsingremittingms AT goldralf endocarditisfollowingocrelizumabinrelapsingremittingms |